MicroRNA profile before and after antiviral therapy in liver transplant recipients for hepatitis C virus cirrhosis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue 1, 2014, Pages 121-127

  Gelley, Fanni ^a   Zadori, Gergely ^a   Nemes, Balazs ^a   Fassan, Matteo ^b   Lendvai, Gabor ^a   Sarvary, Eniko ^a   Doros, Attila ^a   Gerlei, Zsuzsanna ^a   Nagy, Peter ^a   Schaff, Zsuzsa ^a   Kiss, Andras ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

HCV; HCV receptors; Liver transplantation; MicroRNA; SVR

Indexed keywords

INTERFERON; MICRORNA; MICRORNA 122; MICRORNA 125B; MICRORNA 181A 2; MICRORNA 194; MICRORNA 195; MICRORNA 21; MICRORNA 217; MICRORNA 221; MICRORNA 224; MICRORNA 23A; MICRORNA 34A; MICRORNA 96; MICRORNA 99A; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN; UNCLASSIFIED DRUG;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CLINICAL ARTICLE; FEMALE; GRAFT RECIPIENT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT RESPONSE;

HCV; HCV RECEPTORS; LIVER TRANSPLANTATION; MICRORNA; SVR;

ADULT; ANTIVIRAL AGENTS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, VIRAL; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MICRORNAS; MIDDLE AGED; RECEPTORS, VIRUS; RECURRENCE; RNA, VIRAL;

EID: 84897626519     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12362     Document Type: Article

References (41)

1. Khapra AP, Agarwal K, Fiel MI etal. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts. Liver Transpl. 2006; 12: 1496-1503.
2. Mensa L, Crespo G, Gastinger MJ etal. Hepatitis C virus receptors claudin-1 and occludin after liver transplantation and influence on early viral kinetics. Hepatology 2011; 53: 1436-1445.
3. Murakami Y, Tanaka M, Toyoda H etal. Hepatic microRNA expression is associated with the response to interferon treatment of chronic hepatitis C. BMC Med. Genomics 2010; 3: 48.
4. Nakamuta M, Fujino T, Yada R etal. Expression profiles of genes associated with viral entry in HCV-infected human liver. J. Med. Virol. 2011; 83: 921-927.
5. Reynolds GM, Harris HJ, Jennings A etal. Hepatitis C virus receptor expression in normal and diseased liver tissue. Hepatology 2008; 47: 418-427.
6. Zadori G, Gelley F, Torzsok P etal. Examination of claudin-1 expression in patients undergoing liver transplantation owing to hepatitis C virus cirrhosis. Transplant. Proc. 2011; 43: 1267-1271.
7. Poenisch M, Bartenschlager R. New insights into structure and replication of the hepatitis C virus and clinical implications. Semin. Liver Dis. 2010; 30: 333-347.
8. Davidson-Moncada J, Papavasiliou FN, Tam W. MicroRNAs of the immune system: roles in inflammation and cancer. Ann. N. Y. Acad. Sci. 2010; 1183: 183-194.
9. Liu X, Wang T, Wakita T, Yang W. Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells. Virology 2010; 398: 57-67.
10. Neilson JR, Zheng GX, Burge CB, Sharp PA. Dynamic regulation of miRNA expression in ordered stages of cellular development. Genes Dev. 2007; 21: 578-589.
11. Jin X, Chen YP, Kong M, Zheng L, Yang YD, Li YM. Transition from hepatic steatosis to steatohepatitis: unique microRNA patterns and potential downstream functions and pathways. J. Gastroenterol. Hepatol. 2012; 27: 331-340.
12. Lendvai G, Kiss A, Kovalszky I, Schaff Z. [Alterations in microRNA expression patterns in liver diseases]. Orv. Hetil. 2010; 151: 1843-1853.
13. Morita K, Taketomi A, Shirabe K etal. Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C. Liver Int. 2011; 31: 474-484.
14. Schickel R, Boyerinas B, Park SM, Peter ME. MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 2008; 27: 5959-5974.
15. Asselah T, Bieche I, Sabbagh A etal. Gene expression and hepatitis C virus infection. Gut 2009; 58: 846-858.
16. Jopling CL, Schutz S, Sarnow P. Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. Cell Host Microbe 2008; 4: 77-85.
17. Pedersen IM, Cheng G, Wieland S etal. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007; 449: 919-922.
18. Berkhout B. A balancing act: viruses and miRNAs. J. Formos. Med. Assoc. 2008; 107: 1-3.
19. Tombol Z, Szabo PM, Molnar V etal. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis. Endocr. Relat. Cancer 2009; 16: 895-906.
20. Andersen CL, Jensen JL, Orntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004; 64: 5245-5250.
21. Nemes B, Sarvary E, Gerlei Z etal. [The recurrence of hepatitis C virus after liver transplantation]. Orv. Hetil. 2007; 148: 1971-1979.
22. Berenguer M, Lopez-Labrador FX, Wright TL. Hepatitis C and liver transplantation. J. Hepatol. 2001; 35: 666-678.
23. Norman KL, Sarnow P. Hepatitis C virus' Achilles' heel-dependence on liver-specific microRNA miR-122. Cell Res. 2010; 20: 247-249.
24. Dai R, Ahmed SA. MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl. Res. 2011; 157: 163-179.
25. Shenouda SK, Alahari SK. MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer Metastasis Rev. 2009; 28: 369-378.
26. Chang J, Guo JT, Jiang D, Guo H, Taylor JM, Block TM. Liver-specific microRNA miR-122 enhances the replication of hepatitis C virus in nonhepatic cells. J. Virol. 2008; 82: 8215-8223.
27. Henke JI, Goergen D, Zheng J etal. microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J. 2008; 27: 3300-3310.
28. Randall G, Panis M, Cooper JD etal. Cellular cofactors affecting hepatitis C virus infection and replication. Proc. Natl Acad. Sci. U.S.A. 2007; 104: 12884-12889.
29. Buhler S, Bartenschlager R. New targets for antiviral therapy of chronic hepatitis C. Liver Int. 2012; 32 (Suppl. 1): 9-16.
30. Wang XW, Heegaard NH, Orum H. MicroRNAs in liver disease. Gastroenterology 2012; 142: 1431-1443.
31. Sarasin-Filipowicz M, Krol J, Markiewicz I, Heim MH, Filipowicz W. Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat. Med. 2009; 15: 31-33.
32. Meng Z, Fu X, Chen X etal. miR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in mice. Hepatology 2010; 52: 2148-2157.
33. Venugopal SK, Jiang J, Kim TH etal. Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation. Am. J. Physiol. Gastrointest. Liver Physiol. 2010; 298: G101-106.
34. Jazbutyte V, Thum T. MicroRNA-21: from cancer to cardiovascular disease. Curr. Drug Targets 2010; 11: 926-935.
35. Wang Y, Lee CG. Role of miR-224 in hepatocellular carcinoma: a tool for possible therapeutic intervention? Epigenomics 2011; 3: 235-243.
36. Scisciani C, Vossio S, Guerrieri F etal. Transcriptional regulation of miR-224 upregulated in human HCCs by NFkappaB inflammatory pathways. J. Hepatol. 2012; 56: 855-861.
37. Tardif KD, Waris G, Siddiqui A. Hepatitis C virus, ER stress, and oxidative stress. Trends Microbiol. 2005; 13: 159-163.
38. Pineau P, Volinia S, McJunkin K etal. miR-221 overexpression contributes to liver tumorigenesis. Proc. Natl Acad. Sci. U.S.A. 2010; 107: 264-269.
39. Zhang C, Han L, Zhang A etal. Global changes of mRNA expression reveals an increased activity of the interferon-induced signal transducer and activator of transcription (STAT) pathway by repression of miR-221/222 in glioblastoma U251 cells. Int. J. Oncol. 2010; 36: 1503-1512.
40. Estrabaud E, Bieche I, Lapalus M etal. Hepatic miRNA signature associated with treatment response in chronic hepatitis C. Hepatology 2011; 54 (Suppl. 1): 1344A.
41. Coulouarn C, Factor VM, Andersen JB, Durkin ME, Thorgeirsson SS. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties. Oncogene 2009; 28: 3526-3536.